- Home
- NAMS vs BBAR Comparison
NAMS vs BBAR Comparison
Compare NAMS & BBAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAMS | BBAR |
|---|---|---|
| Founded | 2019 | 1886 |
| Country | Netherlands | Argentina |
| Employees | 100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.1B |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | NAMS | BBAR |
|---|---|---|
| Price | $31.78 | $19.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $46.75 | $17.00 |
| AVG Volume (30 Days) | ★ 977.5K | 638.4K |
| Earning Date | 05-06-2026 | 05-20-2026 |
| Dividend Yield | N/A | ★ 2.04% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17.96 | $18.32 |
| Revenue Next Year | $540.65 | $11.04 |
| P/E Ratio | ★ N/A | $26.78 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $21.14 | $7.76 |
| 52 Week High | $42.21 | $22.47 |
Technical Indicators
Market Signals| Indicator | NAMS | BBAR |
|---|---|---|
| Relative Strength Index (RSI) | 42.75 | 50.11 |
| Support Level | $29.23 | $17.03 |
| Resistance Level | $31.72 | $21.76 |
| Average True Range (ATR) | 1.86 | 1.10 |
| MACD | -0.38 | -0.16 |
| Stochastic Oscillator | 13.64 | 23.83 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.
About BBAR Banco BBVA Argentina S.A. ADS
Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.